Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: BEVACIZUMAB, . Treffer: 39

2023

Pujade-Lauraine, E; Brown, J; Barnicle, A; Wessen, J; Lao-Sirieix, P; Criscione, SW; du, Bois, A; Lorusso, D; Romero, I; Petru, E; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Provansal, M; Schmalfeldt, B; Pignata, S; Martín, Lorente, C; Berton, D; Runnebaum, IB; Ray-Coquard, I Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
JCO Precis Oncol. 2023; 7:e2200258 Doi: 10.1200/PO.22.00258 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

2022

Beka, S; Strauss, RW; Podkowinski, D; Mursch-Edlmayr, AS; Mariacher, S; Hofer, AS; Bolz, M Efficacy of a Disease Management Program of a Tertiary Center and Ophthalmologic Practitioners for the Treatment of Neovascular Age-Related Macular Degeneration.
Ophthalmologica. 2022; 245(1):10-18 Doi: 10.1159/000517188
Web of Science PubMed FullText FullText_MUG

 

2021

Keil, M; Conrad, T; Becker, M; Keilholz, U; Yaspo, ML; Lehrach, H; Schütte, M; Haybaeck, J; Hoffmann, J Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data.
Cancers (Basel). 2021; 13(23): Doi: 10.3390/cancers13236018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Bianconi, D; Herac, M; Posch, F; Schmeidl, M; Unseld, M; Kieler, M; Brettner, R; Mullauer, L; Riedl, J; Gerger, A; Scheithauer, W; Prager, G Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
THER ADV MED ONCOL. 2020; 12: 1758835920928635 Doi: 10.1177/1758835920928635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Harter, P; Pautier, P; Van Nieuwenhuysen, E; Reuss, A; Redondo, A; Lindemann, K; Kurzeder, C; Petru, E; Heitz, F; Sehouli, J; Degregorio, N; Wimberger, P; Burges, A; Cron, N; Ledermann, J; Lorusso, D; Paoletti, X; Marme, F Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34).
Int J Gynecol Cancer. 2020; 30(12): 1997-2001. Doi: 10.1136/ijgc-2020-001572
Web of Science PubMed FullText FullText_MUG

 

Zhou, Q; Perakis, SO; Ulz, P; Mohan, S; Riedl, JM; Talakic, E; Lax, S; Tötsch, M; Hoefler, G; Bauernhofer, T; Pichler, M; Gerger, A; Geigl, JB; Heitzer, E; Speicher, MR Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer.
Genome Med. 2020; 12(1):20 Doi: 10.1186/s13073-020-0719-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Kroeze, SGC; Fritz, C; Basler, L; Gkika, E; Brunner, TB; Grosu, AL; Guckenberger, M Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries.
Strahlenther Onkol. 2019; 195(3):199-206 Doi: 10.1007/s00066-018-01422-5
Web of Science PubMed FullText FullText_MUG

 

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Palkovits, S; Seidel, G; Pertl, L; Malle, EM; Hausberger, S; Makk, J; Singer, C; Osterholt, J; Herzog, SA; Haas, A; Weger, M MACULAR CHOROIDAL VOLUME CHANGES AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Retina. 2017; 37(12):2262-2268 Doi: 10.1097/IAE.0000000000001480
Web of Science PubMed FullText FullText_MUG

 

2016

Smretschnig, E; Hagen, S; Glittenberg, C; Ristl, R; Krebs, I; Binder, S; Ansari-Shahrezaei, S Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Eye (Lond). 2016; 30(6):805-811 Doi: 10.1038/eye.2016.41 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Svejda, B; Muschitz, Ch; Gruber, R; Brandtner, Ch; Svejda, Ch; Gasser, RW; Santler, G; Dimai, HP [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Wien Med Wochenschr. 2016; 166(1-2):68-74 Doi: 10.1007/s10354-016-0437-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Benesch, M; Lackner, H; Pilhatsch, A; Gürtl-Lackner, B; Schwinger, W; Urban, C Long-term Remission in a Female With Multiple Relapsed Juvenile Granulosa Cell Tumor.
J Pediatr Hematol Oncol. 2015; 37(8):e486-e489 Doi: 10.1097/MPH.0000000000000387 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Riss, D; Burian, M; Wolf, A; Kranebitter, V; Kaider, A; Arnoldner, C Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Head Neck. 2015; 37(6):783-787 Doi: 10.1002/hed.23655
Web of Science PubMed FullText FullText_MUG

 

2014

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 Doi: 10.1158/1078-0432.CCR-13-1440 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schweneker, K; Clemm, C; Brügel, M; Souvatzoglou, M; Hermisson, M; Schmidt-Graf, F; Zimmer, C; Peschel, C; Jost, PJ Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature.
Exp Hematol Oncol. 2014; 3(16):29-29 Doi: 10.1186/2162-3619-3-29 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Smolle, E; Taucher, V; Haybaeck, J Malignant ascites in ovarian cancer and the role of targeted therapeutics.
Anticancer Res. 2014; 34(4):1553-1561
Web of Science PubMed

 

Stiegelbauer, V; Perakis, S; Deutsch, A; Ling, H; Gerger, A; Pichler, M MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
World J Gastroenterol. 2014; 20(33):11727-11735 Doi: 10.3748/wjg.v20.i33.11727 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Krebs, I; Glittenberg, C; Ansari-Shahrezaei, S; Hagen, S; Steiner, I; Binder, S Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
Br J Ophthalmol. 2013; 97(11):1443-1446 Doi: 10.1136/bjophthalmol-2013-303513 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Schmetterer, L; Boltz, A; Told, R; Vécsei-Marlovits, V; Egger, S; Schönherr, U; Haas, A; Ansari-Shahrezaei, S; Binder, S; MANTA Research Group A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration.
Br J Ophthalmol. 2013; 97(3):266-271 Doi: 10.1136/bjophthalmol-2012-302391
Web of Science PubMed FullText FullText_MUG

 

Michelitsch, M; Gasser-Steiner, V; Gasser-Steiner, P; The incidence and treatment of diabetic macular edema at the University Eye-Clinic Graz for a period of 2 years.
SPEKTRUM AUGENHEILKD. 2013; 27(5): 234-238. Doi: 10.1007/s00717-013-0185-2
Web of Science FullText FullText_MUG

 

Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203 Doi: 10.1097/CAD.0b013e32835b9589
Web of Science PubMed FullText FullText_MUG

 

Smolle, E; Taucher, V; Pichler, M; Petru, E; Lax, S; Haybaeck, J Targeting signaling pathways in epithelial ovarian cancer.
Int J Mol Sci. 2013; 14(5):9536-9555 Doi: 10.3390/ijms14059536 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Strenger, V; Lackner, H; Mayer, R; Sminia, P; Sovinz, P; Mokry, M; Pilhatsch, A; Benesch, M; Schwinger, W; Seidel, M; Sperl, D; Schmidt, S; Urban, C Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.
Strahlenther Onkol. 2013; 189(9):759-764 Doi: 10.1007/s00066-013-0408-0
Web of Science PubMed FullText FullText_MUG

 

2012

Dunavoelgyi, R; Sacu, S; Eibenberger, K; Palkovits, S; Leydolt, C; Pruente, C; Schmidt-Erfurth, U Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.
Retina. 2012; 32(8): 1471-1479. Doi: 10.1097/IAE.0b013e318236e805
Web of Science PubMed FullText FullText_MUG

 

Grunewald, TGP; Greulich, N; Kontny, U; Fruhwald, M; Rutkowski, S; Kordes, U; Scheurlen, W; Schmidt, W; Stachel, D; Metzler, M; Mittler, U; Graf, N; Benesch, M; Burdach, S Targeted Therapeutics in Treatment of Children and Young Adults with Solid Tumors: an Expert Survey and Review of the Literature
Klin Padiatr. 2012; 224(3):124-131 Doi: 10.1055/s-0032-1301930
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Geist, C; Dahlbom, M; Silverman, DH; Satyamurthy, N; Phelps, ME; Chen, W 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
J Nucl Med. 2012; 53(1):29-36 Doi: 10.2967/jnumed.111.092387 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tarmann, L; Wedrich, A; Haas, A; Berghold, A; Kresse, A; Vajda, C; Maier, R; Limited vitrectomy with intravitreal bevacizumab, rt-PA and gas for submacular hemorrhage due to age-related macular degeneration.
SPEKTRUM AUGENHEILKD. 2012; 26(4): 197-201. Doi: 10.1007/s00717-012-0119-4
Web of Science FullText FullText_MUG

 

2011

Gerger, A; Labonte, M; Lenz, HJ Molecular predictors of response to antiangiogenesis therapies.
Cancer J. 2011; 17(2):134-141 Doi: 10.1097/PPO.0b013e318212db3c
Web of Science PubMed FullText FullText_MUG

 

Schmid-Kubista, KE; Krebs, I; Ansari-Shahrezaei, S; Haas, P; Hagen, S; Binder, S Comparing treatment of neovascular age-related macular degeneration with sequential intravitreal Avastin and Macugen versus intravitreal mono-therapy--a pilot study.
Curr Eye Res. 2011; 36(10):958-963 Doi: 10.3109/02713683.2011.597536
Web of Science PubMed FullText FullText_MUG

 

2010

Moussa, S; Ansari-Shahrezaei, S; Smretschnig, E; Hagen, S; Steindl-Kuscher, K; Krebs, I; Binder, S Contrast sensitivity after intravitreal antivascular endothelial growth factor therapy for myopic choroidal neovascularization.
Graefes Arch Clin Exp Ophthalmol. 2010; 248(8):1087-1090 Doi: 10.1007/s00417-010-1341-x
Web of Science PubMed FullText FullText_MUG

 

Prager, GW; Lackner, EM; Krauth, MT; Unseld, M; Poettler, M; Laffer, S; Cerny-Reiterer, S; Lamm, W; Kornek, GV; Binder, BR; Zielinski, CC; Valent, P Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Mol Oncol. 2010; 4(2): 150-160. Doi: 10.1016/j.molonc.2010.01.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zhang, W; Azuma, M; Lurje, G; Gordon, MA; Yang, D; Pohl, A; Ning, Y; Bohanes, P; Gerger, A; Winder, T; Hollywood, E; Danenberg, KD; Saltz, L; Lenz, HJ Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study).
Anticancer Res. 2010; 30(10):4209-4217
Web of Science PubMed

 

2009

Weiss, K; Steinbrugger, I; Weger, M; Ardjomand, N; Maier, R; Wegscheider, BJ; Wedrich, A; El-Shabrawi, Y Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
Eye. 2009; 23(9): 1812-1818. Doi: 10.1038/eye.2008.388 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Benesch, M; Windelberg, M; Sauseng, W; Witt, V; Fleischhack, G; Lackner, H; Gadner, H; Bode, U; Urban, C Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.
Ann Oncol. 2008; 19(4): 807-813. Doi: 10.1093/annonc/mdm510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kook, D; Wolf, A; Kreutzer, T; Neubauer, A; Strauss, R; Ulbig, M; Kampik, A; Haritoglou, C Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Retina. 2008; 28(8):1053-1060 Doi: 10.1097/IAE.0b013e318176de48
Web of Science PubMed FullText FullText_MUG

 

Krebs, I; Ansari-Shahrezaei, S; Goll, A; Binder, S Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography.
Graefes Arch Clin Exp Ophthalmol. 2008; 246(6):811-815 Doi: 10.1007/s00417-007-0755-6
Web of Science PubMed FullText FullText_MUG

 

2007

D'Angelica, M; Kornprat, P; Gonen, M; Chung, KY; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kemeny, N; Blumgart, LH; Saltz, LB Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study.
Ann Surg Oncol. 2007; 14(2):759-765 Doi: 10.1245/s10434-006-9074-0
Web of Science PubMed FullText FullText_MUG

 

Priglinger, SG; Wolf, AH; Kreutzer, TC; Kook, D; Hofer, A; Strauss, RW; Alge, CS; Kunze, C; Haritoglou, C; Kampik, A Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.
Retina. 2007; 27(8):1004-1012 Doi: 10.1097/IAE.0b013e3180ed458d
Web of Science PubMed FullText FullText_MUG

 

Terheyden, P; Hofmann, MA; Weininger, M; Brocker, EB; Becker, JC Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma.
J Cancer Res Clin Oncol. 2007; 133(11):897-901 Doi: 10.1007/s00432-007-0251-8 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum